Ting KKY, Jongstra-Bilen J, Cybulsky MI
10 As shown in FIGURE 3 , exenatide normalizes blood glucose levels by reducing fasting and postprandial glucose concentrations through a variety of mechanisms, including enhanced glucose-dependent insulin secretion, regulation of glucagon secretion, delayed gastric emptying, and decreased food intake due to centrally mediated effects on satiety
Summary: GLP-1 receptor agonists are not licensed or recommended for ADHD treatment in the UK, and no robust clinical evidence supports their use for ADHD symptoms
The second is standard medical practice
Wagner C, Bonnardel J, Da Silva C, Martens L, Gorvel JP, Lelouard H (2018) Some news from the unknown soldier, the Peyers patch macrophage
Effect sizes are not uniform, though